Nektar Therapeutics
IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD

Abstract:

Provided is a method of administering to a patient having cancer: (a) a 4-1BB agonist; (b) an IL-2R.beta.-activating amount of a long-acting, IL-2R.beta.-selective agonist; and/or (c) a toll-like receptor agonist, as well as related compositions, kits and compositions.